Dietary Supplement & Cosmetics Legal Bulletin | December 2017

JD Supra (press release)-Dec 13, 2017

The U.S. International Trade Commission (ITC) has reportedly declined to investigate a complaint filed by Amarin Pharma Inc. that alleged 18 companies falsely categorize unapproved new drugs containing omega-3 acids as dietary supplements. The complaint alleged that false labeling allows the companies to avoid .